UBS Group’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41K | Buy |
14,417
+12,565
| +678% | +$35.7K | ﹤0.01% | 6635 |
|
|
2025
Q1 | $4.06K | Sell |
1,852
-15,578
| -89% | -$34.1K | ﹤0.01% | 7839 |
|
|
2024
Q4 | $46.9K | Buy |
17,430
+4,700
| +37% | +$12.6K | ﹤0.01% | 6124 |
|
|
2024
Q3 | $39.1K | Buy |
12,730
+12,134
| +2,036% | +$37.3K | ﹤0.01% | 5775 |
|
|
2024
Q2 | $2.53K | Buy |
596
+591
| +11,820% | +$2.51K | ﹤0.01% | 7179 |
|
|
2024
Q1 | $17 | Sell |
5
-442
| -99% | -$1.5K | ﹤0.01% | 7881 |
|
|
2023
Q4 | $1.61K | Buy |
+447
| New | +$1.61K | ﹤0.01% | 7050 |
|
|
2023
Q1 | – | Sell |
-146
| Closed | -$3.28K | – | 8978 |
|
|
2022
Q4 | $3.28K | Sell |
146
-129
| -47% | -$2.9K | ﹤0.01% | 8340 |
|
|
2022
Q3 | $12K | Buy |
275
+241
| +709% | +$10.5K | ﹤0.01% | 7078 |
|
|
2022
Q2 | $2K | Sell |
34
-153
| -82% | -$9K | ﹤0.01% | 8566 |
|
|
2022
Q1 | $15K | Buy |
187
+115
| +160% | +$9.23K | ﹤0.01% | 6799 |
|
|
2021
Q4 | $7K | Sell |
72
-61
| -46% | -$5.93K | ﹤0.01% | 8041 |
|
|
2021
Q3 | $15K | Buy |
133
+33
| +33% | +$3.72K | ﹤0.01% | 6379 |
|
|
2021
Q2 | $15K | Buy |
+100
| New | +$15K | ﹤0.01% | 6550 |
|
|
2021
Q1 | – | Sell |
-56
| Closed | -$8K | – | 8198 |
|
|
2020
Q4 | $8K | Sell |
56
-3
| -5% | -$429 | ﹤0.01% | 6607 |
|
|
2020
Q3 | $10K | Buy |
+59
| New | +$10K | ﹤0.01% | 5985 |
|
|
2020
Q2 | – | Sell |
-30
| Closed | -$3K | – | 7293 |
|
|
2020
Q1 | $3K | Sell |
30
-105
| -78% | -$10.5K | ﹤0.01% | 6592 |
|
|
2019
Q4 | $12K | Buy |
135
+17
| +14% | +$1.51K | ﹤0.01% | 6118 |
|
|
2019
Q3 | $14K | Sell |
118
-80
| -40% | -$9.49K | ﹤0.01% | 5992 |
|
|
2019
Q2 | $31K | Buy |
198
+122
| +161% | +$19.1K | ﹤0.01% | 5440 |
|
|
2019
Q1 | $13K | Sell |
76
-20
| -21% | -$3.42K | ﹤0.01% | 5807 |
|
|
2018
Q4 | $12K | Buy |
96
+64
| +200% | +$8K | ﹤0.01% | 6222 |
|
|
2018
Q3 | $8K | Buy |
32
+3
| +10% | +$750 | ﹤0.01% | 6365 |
|
|
2018
Q2 | $13K | Buy |
29
+3
| +12% | +$1.35K | ﹤0.01% | 6077 |
|
|
2018
Q1 | $17K | Buy |
26
+1
| +4% | +$654 | ﹤0.01% | 5639 |
|
|
2017
Q4 | $24K | Buy |
25
+19
| +317% | +$18.2K | ﹤0.01% | 5448 |
|
|
2017
Q3 | $5K | Sell |
6
-3
| -33% | -$2.5K | ﹤0.01% | 6313 |
|
|
2017
Q2 | $12K | Buy |
9
+3
| +50% | +$4K | ﹤0.01% | 5708 |
|
|
2017
Q1 | $8K | Sell |
6
-5
| -45% | -$6.67K | ﹤0.01% | 5832 |
|
|
2016
Q4 | $10K | Sell |
11
-12
| -52% | -$10.9K | ﹤0.01% | 5964 |
|
|
2016
Q3 | $18K | Buy |
+23
| New | +$18K | ﹤0.01% | 5489 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6908 |
|
|
2016
Q1 | – | Sell |
-2
| Closed | -$2K | – | 6848 |
|
|
2015
Q4 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 6595 |
|
|
2015
Q3 | – | Sell |
-5
| Closed | -$6K | – | 6937 |
|
|
2015
Q2 | $6K | Sell |
5
-15
| -75% | -$18K | ﹤0.01% | 6226 |
|
|
2015
Q1 | $15K | Buy |
20
+15
| +300% | +$11.3K | ﹤0.01% | 5611 |
|
|
2014
Q4 | $7K | Buy |
+5
| New | +$7K | ﹤0.01% | 6188 |
|